Proteomics Services Market Size, Growth, Share & Trends Analysis
Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The proteomics services market is projected to reach USD 16.46 billion by 2030 from USD 8.77 billion in 2025, at a CAGR of 13.4%.This growth is driven by advances in multiplexing, automation, and bioinformatics, which enable deeper analysis of protein interactions, biomarker discovery, and assay development, improving insights into therapeutic responses, diagnostics, and functional applications.
KEY TAKEAWAYS
-
BY RegionAsia Pacific is expected to be the fastest-growing proteomics service market at a CAGR if 14.8% during the forecast period.
-
BY Service TypeBy service type, the core proteomics services segment is expected to dominate the market throughout the forecast period.
-
BY ApplicationBy application, the drug discovery & development segment accounted for the largest share of 47.0% in 2024.
-
BY End UserBy end user, biopharmaceutical companies dominated by 40.0% of the proteomics services market share in 2024.
-
COMPETITIVE LANDSCAPE - Key PlayersThermofisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US) were identified as star players in the proteomics service market, given their strong market share and product footprint.
-
COMPETITIVE LANDSCAPE - Startups/SMEsPixelgen Technologies AB (Sweden), MSAID GmbH (Germany), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The proteomics services market is expanding robustly, supported by surging biopharma investments orchestrating therapeutic-clinical collaborations, and rising adoption of sophisticated services for biomarker validation. Advanced proteomics service platforms empower researchers and clinicians to decode protein signaling networks, accelerate the development of companion diagnostics, and optimize the prediction of immunotherapy response.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The proteomics services market is driven by fast-moving scientific, regulatory, and clinical trends set to intensify over the forecast period. Expanding applications in precision oncology, immunology, and neurodegenerative diseases, alongside surging clinical trial integration, are driving demand for multiplex, reproducible platforms in diagnostics and biopharma R&D. The proteomics services market is undergoing significant disruption as customers shift from low-throughput, single-protein assays toward high-throughput, standardized, and integrated proteomic workflows. Growing demand from pharmaceutical, clinical, and academic clients is driving the adoption of companion diagnostics, multiplexed panels, and end-to-end biomarker profiling. These trends are enabling faster biomarker discovery, improved data reproducibility, scalable automation, and more actionable insights across drug discovery, diagnostics, and translational research.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing outsourcing of biopharmaceutical R&D activities
-
Expansion of clinical and translational research
Level
-
High service costs restricting access to smaller organizations
Level
-
Emergence of integrated multi-omics service offerings
Level
-
Shortage of expertise to analyze high-dimensional dat
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing outsourcing of biopharmaceutical R&D activities
Pharmaceutical and biotechnology companies are increasingly outsourcing proteomics to specialized service providers to accelerate R&D for drug discovery and translational research. This trend allows sponsors to access advanced technologies and expertise without significant capital investment.
Restraint: High service costs restricting access to smaller organizations
Advanced proteomics services involve premium pricing due to sophisticated instrumentation and analytical complexity. These high costs limit adoption among small biotech firms and academic institutions with constrained R&D budgets.
Opportunity: Emergence of integrated multi-omics service offerings
The convergence of proteomics with genomics, metabolomics, and single-cell analysis enables deeper biological insights across drug development stages. Service providers offering integrated multi-omics platforms can deliver differentiated, higher-value solutions.
Challenge: Shortage of expertise to analyze high-dimensional data
Proteomics generates large, complex datasets that require specialized bioinformatics and statistical expertise. The limited availability of skilled professionals creates bottlenecks in data interpretation and decision-making.
PROTEOMICS SERVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides end-to-end proteomics services through contract research, combining mass spectrometry, targeted protein assays, and advanced bioinformatics to support discovery, translational, and clinical studies for pharma, biotech, and academic clients | Enables rapid, high-quality protein profiling without in-house infrastructure | accelerates biomarker discovery and validation | supports scalable studies across preclinical and clinical pipelines |
 |
Offers integrated proteomics services embedded within drug discovery and safety assessment programs, supporting target identification, mechanism-of-action studies, and translational biomarker development | Reduces program risk by aligning proteomic insights with pharmacology and toxicology data | improves decision-making across drug development stages |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The proteomics services market comprises contract research organizations, proteomics service organizations, core research organizations, biopharma companies, and clinical labs that are interconnected as part of the value chain. Service organizations offer fully integrated proteomics analytical workflows such as sample preparation, high-throughput mass spectrometry analysis, targeted and quantitative proteomics analysis, and advanced proteomics analysis and bioinformatics analysis and interpretation. CROs and core research organizations perform complex high-resolution protein profiling analyses as part of the services offered, and biopharma companies and healthcare organizations take advantage of the services provided to them for the identification, qualification, and translation of high-sensitivity protein biomarkers into clinical practice and applications based on proteomic analysis and interpretation.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Proteomics Services Market, By Service Type
In 2024, core proteomics services led the market, driven by demand for protein identification, characterization, and quantitative analysis, which are essential for drug discovery and biomarker research.
Proteomics Services Market, By Application
Drug discovery & development dominated the market for the application segment in 2024 due to intensive use in target identification, biomarker validation, and protein interaction mapping critical for novel therapeutics, outpacing diagnostics and clinical research.
Proteomics Services Market, By End User
In 2024, biopharmaceutical companies held the largest market share by end user owing to their extensive reliance on proteomics for drug discovery, biomarker validation, and biologics development.
REGION
Asia Pacific to be fastest-growing market for proteomics services during forecast period
During the forecast period, Asia Pacific is expected to be the fastest-growing market for proteomics services, driven by the ongoing expansion of biopharmaceutical R&D capacity. Strong pipelines in biologics, biomarker research, and precision therapies, along with increased investments by major pharmaceutical companies in advanced proteomics platforms and facility upgrades, are boosting the adoption of high-throughput services across both new and existing laboratories.
PROTEOMICS SERVICES MARKET: COMPANY EVALUATION MATRIX
In the proteomics services market matrix, Thermo Fisher is the clear star player due to its comprehensive proteomics services, global service networks, integration with high-end instrumentation, advanced bioinformatics pipelines, and broad adoption by biopharma, CROs, and clinical research centers. Eurofins Scientific is positioned as an emerging leader in the proteomics services market due its expanding lab footprint, strong contract research service portfolio, depth in bioanalytical and proteomic analysis, and growing participation in translational and clinical proteomics projects.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Agilent Technologies, Inc. (US)
- Revvity, Inc. (US)
- Illumina, Inc. (US)
- Eurofins Scientific (Luxembourg)
- Charles River Laboratories (US)
- Protagen AG (Germany)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 8.06 Billion |
| Market Size in 2030 (Value) | USD 16.46 Billion |
| Growth Rate | CAGR of 13.4% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
WHAT IS IN IT FOR YOU: PROTEOMICS SERVICES MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| End-to-end service integration | Assessed how proteomics service providers integrate sample logistics, wet-lab analysis, bioinformatics, and reporting into unified service offerings across discovery and clinical research projects | Helps biopharma and CRO clients reduce vendor fragmentation, shorten project timelines, and improve accountability across complex proteomics studies |
| Clinical and regulatory readiness | Evaluated service providers’ compliance with GLP/GCLP standards, data traceability, audit readiness, and experience supporting regulated clinical and biomarker validation studies | Enables sponsors to confidently select partners capable of supporting late-stage drug development and diagnostic validation programs |
RECENT DEVELOPMENTS
- March 2025 : Eurofins expanded the analytical and proteomics-related service capabilities by adopting Olink’s high-throughput proteomics technology.
- October 2025 : Charles River and Proteome Systems launched a dedicated proteomics services business to provide high-end proteomic testing and analysis on a contract basis, enhancing their service portfolio for drug discovery and biomarker research.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current size of the asia pacific proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (asia pacific proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the asia pacific proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global asia pacific proteomics market, which was then validated by primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Proteomics Services Market Size Estimation
A top-down approach was used to estimate and validate the total size of the asia pacific proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total asia pacific proteomics market size includes the following:
Data Triangulation
After arriving at the overall asia pacific proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Asia Pacific Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in asia pacific proteomics.
Key Stakeholders
- Life sciences instrumentation and reagent companies
- Pharmaceutical and biotechnology companies
- Asia Pacific Proteomics database and software providers
- Asia Pacific Proteomics service providers
- Research and consulting firms
- Academic medical centers
- Government research organizations
- Clinical research institutes
- Contract Research Organizations
Report Objectives
- To define, describe, and forecast the global asia pacific proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall asia pacific proteomics market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
- To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the asia pacific proteomics market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographic Analysis
- Further breakdown of the Rest of Europe asia pacific proteomics market into respective countries
- Further breakdown of the Rest of Asia Pacific asia pacific proteomics market into respective countries
- Further breakdown of the Rest of Latin America asia pacific proteomics market into respective countries
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
- An additional five company profiles
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Proteomics Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Proteomics Services Market